MedVentive
Total Raised
$31.95MInvestors Count
10Deal Terms
2Funding, Valuation & Revenue
9 Fundings
MedVentive has raised $31.95M over 9 rounds.
MedVentive's latest funding round was a Acquired for on September 24, 2012.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
9/24/2012 | Acquired | 1 | ||||
10/21/2011 | Debt | |||||
10/21/2011 | Series D | |||||
5/27/2011 | Series C - III | |||||
2/19/2010 | Series C - II |
Date | 9/24/2012 | 10/21/2011 | 10/21/2011 | 5/27/2011 | 2/19/2010 |
|---|---|---|---|---|---|
Round | Acquired | Debt | Series D | Series C - III | Series C - II |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
MedVentive Deal Terms
2 Deal Terms
MedVentive's deal structure is available for 2 funding rounds, including their Series B from May 12, 2008.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
MedVentive Investors
10 Investors
MedVentive has 10 investors. McKesson invested in MedVentive's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/24/2012 | 9/24/2012 | 1 Acquired | Corporation | Texas | ||
10/23/2006 | 10/21/2011 | 7 Series C, Series C - II (2010), Series A (2006), Series B (2008), Series C - III (2011), Debt (2011), Series D (2011) | Venture Capital | Massachusetts | ||
7/6/2009 | 10/21/2011 | 5 Series C, Series C - II (2010), Series C - III (2011), Debt (2011), Series D (2011) | Venture Capital | DC | ||
Venture Capital | Massachusetts | |||||
Venture Capital | Massachusetts |
First funding | 9/24/2012 | 10/23/2006 | 7/6/2009 | ||
|---|---|---|---|---|---|
Last Funding | 9/24/2012 | 10/21/2011 | 10/21/2011 | ||
Investor | |||||
Rounds | 1 Acquired | 7 Series C, Series C - II (2010), Series A (2006), Series B (2008), Series C - III (2011), Debt (2011), Series D (2011) | 5 Series C, Series C - II (2010), Series C - III (2011), Debt (2011), Series D (2011) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Venture Capital | Venture Capital |
Location | Texas | Massachusetts | DC | Massachusetts | Massachusetts |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare MedVentive to Competitors
Apixio provides a platform to transform actionable information from healthcare data. Its platform offers access to medical records for healthcare decision-making by helping in finding data that was previously trapped in unstructured medical record systems. The company was founded in 2009 and is based in San Mateo, California.
Carta Healthcare provides analysis and insights into clinical data backed technology and experienced clinicians, the company delivers registry data abstraction, reporting, and analytics to leading healthcare systems nationwide. The company was founded in 2017 and is based in San Francisco, California.
Wellnecity Group is a healthcare technology solutions provider that aims to deliver financial savings, improved population health, and better individual health for US employers and their employees.
MDI Health develops a framework for artificial pharmacology intelligence. It uses technology, methodology, and algorithms to ensure early detection of potential medication-related problems (MRPs) during a drug treatment regimen. It is an add-on to electronic health records systems (EHRs) supporting physicians and helping them take more informed medication-related decisions and provide personalized multi-drug treatment. The company was founded in 2019 and is based in Tel Aviv, Israel.
Nuna is a healthcare technology company that seeks to help make high-quality healthcare affordable and accessible for everyone. The company does this by building data solutions for healthcare payers and providers to measure and improve their cost and quality outcomes.
Nudge is a health engagement science technologies company that delivers organizational solutions for engaging 21st century health consumers. The company allows users to customize a coaching app for their clients. The mobile apps are designed for coaching, training and educational programs. The firm was founded in 2012 and is based in Richmond, Virginia.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
